Skip to main content
. 2023 Oct 4;55(2):2264318. doi: 10.1080/07853890.2023.2264318

Table 3.

Comparison of secondary clinical outcomes between the treated and control groups.

Variables Total ( n=404 ) Treated ( n=203 ) Control ( n=201 )  p-value
7-day mortality, n(%) 41 (10.15) 14 (6.90) 27 (13.43) 0.030*
Hospital mortality, n(%) 108 (26.73) 43 (21.18) 65 (32.34) 0.011*
Hospital LOS, median (Q1, Q3) 9 (7, 12) 10 (7, 13) 9 (6, 12) 0.068
Vasopressor free days in 7 days, median (Q1, Q3) 5 (0, 6) 5.5 (1, 6) 4 (0, 5.5) 0.001*
*

p<0.05 means the difference is statistically significant. LOS length of stay.